Search
Close this search box.
Press Release

CluePoints CEO, Francois Torche, To Present At SCOPE Summit For Clinical Ops Executives

The 8th Annual SCOPE Summit for Clinical Ops Executives, taking place on January 24-26, 2017 in Miami, FL, will offer three stimulating days of in-depth discussions in 13 different conferences, six pre-conference workshops, and two symposia focused on issues related to each aspect of clinical trial planning and management.

Francois Torche, CEO, CluePoints will lead a session entitled “RBM Demystified: What We’ve Learned from the Practical Implementation of RBM and what the Regulators Want.” The session will take place on Wednesday, January 25th at 11:40 am.

Key objectives for Francois’ session include:

  • Best practice for Risk-Based Monitoring study planning process
  • Key pitfalls to avoid
  • How to differentiate between risk assessment, Key Risk Indicators (KRIs), and Data Quality Oversight Methods
  • How other Sponsors and CROs are leveraging a Risk-Based approach to monitoring and satisfying regulatory requirements

If you haven’t signed up for SCOPE Summit for Clinical Ops Executives, you can save $200 on registration using the following discount code: CLUE

Also, be sure to stop by our booth (#509) to explore the data-driven approach to quality oversight and learn more about how our recent agreement with the FDA is driving how the regulator is interrogating submission data to select sites for inspection

See you there!

Press Release
CluePoints Appoints Richard Young as Chief Strategy Officer
Press Release
CluePoints Wins Growth Award at BVA Private Equity Awards
Press Release
CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review